|
Syrov A.V.
Indapamide in the treatment of arterial hypertension
|
№4 / 2023
|
|
Polyakova O.A., Ostroumova O.D. , Arablinsky A.V.
Drug safety and polymorbidity as important components of rational pharmacotherapy in cardiology
|
№4 / 2022
|
|
Syrov A.V.
Use of indapamide in clinical practice
|
№10 / 2021
|
|
Trukhan D.I., Filimonov S.N.
Treatment of arterial hypertension I–II stages in patients with risk of cardiovascular complications above moderate in real clinical practice: possibilities of indapamide in a combined therapy
|
№5 / 2021
|
|
Trukhan D.I., Davydov E.L., Drokina O.V.
Rational pharmacotherapy of arterial hypertension in real clinical practice through the prism of drug safety and multimorbidity
|
№2 / 2021
|
|
Syrov A.V., Minushkina L.O.
Choosing the optimal thiazide-like diuretic in patients with arterial hypertension
|
№1 / 2021
|
|
L.A. Andreeva, L.A. Panchenkova, A.I. Martynov, E.A. Troshina, K.A. Khamidova, E.E. Kazanceva, L.A. Medvedeva, G.G. Karnuta, T.E. Yurkova
Dayly dynamics of indices of central aortic pressure and arterial stiffness in patients with arterial hypertension in the composition of a metabolic syndrome at the background of a fixed-dose combination of perindopril arginine and indapamide
|
№1 / 2018
|
|
A.G. Yevdokimova, V.V. Yevdokimov, Ye.V. Kovalenko, K.I. Tebloyev
Clinical efficacy of fixed-dose combination antihypertensive therapy (focus on Hypotef)
|
№6 / 2016
|
|
M.Ye. Statsenko, М.V. Derevyanchenko
Influence of the combined antihypertensive therapy on renal function and insulin resistance in patients with hypertension and type 2 diabetes
|
№5 / 2016
|
Русский
